MedTrace Logo

Apnoea-Hypopnoea-Indices Determined Via Continuous Positive Airway Pressure vs Those Determined by Polysomnography

NCT04526366 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2021-10-19

No results posted yet for this study

Summary

To date, no published systematic review and meta-analysis has compared AHI-CPAPflow and AHI-PSGgold. Therefore, the primary objective of this study is to compare published data for AHI-PSGgold and AHI-CPAPflow in patients treated by CPAP.

Conditions

  • Sleep Apnea Syndromes

Interventions

DEVICE

Continuous Positive Airway Pressure

Continuous Positive Airway Pressure device deployed for at least one night synchronously with polysomnography.

DEVICE

Polysomnography

Polysomnography deployed for at least one night synchronously with Continuous Positive Airway Pressure.

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Dany Jaffuel, MD,PhD · University Hospitals of Montpellier

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04526366 on ClinicalTrials.gov